Long-term efficacy and safety of erenumab in migraine prevention: results from a 5-year, open-label treatment phase of a randomized clinical trial - Ashina, M; Goadsby, PJ; Reuter, U; Silberstein, S; Dodick, DW; Xue, F (Eur J Neurol, 2021)